[go: up one dir, main page]

DK131277A - Fremgangsmade til fremstilling af antibakterielle forbindelser - Google Patents

Fremgangsmade til fremstilling af antibakterielle forbindelser

Info

Publication number
DK131277A
DK131277A DK131277A DK131277A DK131277A DK 131277 A DK131277 A DK 131277A DK 131277 A DK131277 A DK 131277A DK 131277 A DK131277 A DK 131277A DK 131277 A DK131277 A DK 131277A
Authority
DK
Denmark
Prior art keywords
procedure
antibacterial compounds
making antibacterial
making
compounds
Prior art date
Application number
DK131277A
Other languages
English (en)
Other versions
DK161331B (da
DK161331C (da
Inventor
M Narisada
W Nagata
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK131277A publication Critical patent/DK131277A/da
Publication of DK161331B publication Critical patent/DK161331B/da
Application granted granted Critical
Publication of DK161331C publication Critical patent/DK161331C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK131277A 1976-03-25 1977-03-24 Analogifremgangsmaade til fremstilling af 7beta-substitueret malonamido-1-oxadethia-7alfa-methoxy-3-(1-methyltetrazol-5-yl)thiomethyl-cephalosporiner DK161331C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP3340176 1976-03-25
JP5029576 1976-04-30
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (3)

Publication Number Publication Date
DK131277A true DK131277A (da) 1977-09-26
DK161331B DK161331B (da) 1991-06-24
DK161331C DK161331C (da) 1991-12-09

Family

ID=26372085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131277A DK161331C (da) 1976-03-25 1977-03-24 Analogifremgangsmaade til fremstilling af 7beta-substitueret malonamido-1-oxadethia-7alfa-methoxy-3-(1-methyltetrazol-5-yl)thiomethyl-cephalosporiner

Country Status (19)

Country Link
AR (1) AR224606A1 (da)
BG (1) BG31074A3 (da)
CY (1) CY1158A (da)
DD (1) DD129792A5 (da)
DE (1) DE2713370C2 (da)
DK (1) DK161331C (da)
ES (5) ES457174A1 (da)
GR (1) GR61146B (da)
HK (1) HK46882A (da)
HU (1) HU172720B (da)
IE (1) IE44794B1 (da)
IL (1) IL51743A (da)
MX (1) MX4348E (da)
NO (2) NO158505C (da)
NZ (1) NZ183687A (da)
PT (1) PT66346B (da)
RO (2) RO78228A (da)
SE (1) SE443143B (da)
YU (2) YU44039B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
IE44794B1 (en) 1982-04-07
NO158505B (no) 1988-06-13
MX4348E (es) 1982-04-05
DK161331B (da) 1991-06-24
HU172720B (hu) 1978-11-28
DD129792A5 (de) 1978-02-08
YU173883A (en) 1983-12-31
ES469284A1 (es) 1978-11-16
YU44038B (en) 1990-02-28
DE2713370C2 (de) 1994-04-21
SE7703325L (sv) 1977-09-26
ES469285A1 (es) 1979-09-16
DK161331C (da) 1991-12-09
YU44039B (en) 1990-02-28
ES469286A1 (es) 1979-09-16
DE2713370A1 (de) 1977-09-29
NO158505C (no) 1988-09-21
NO771023L (no) 1977-09-27
RO71742A (ro) 1982-02-26
IE44794L (en) 1977-09-25
NZ183687A (en) 1979-01-11
SE443143B (sv) 1986-02-17
IL51743A (en) 1980-10-26
GR61146B (en) 1978-09-27
AR224606A1 (es) 1981-12-30
ES457174A1 (es) 1978-08-16
CY1158A (en) 1983-01-28
RO78228A (ro) 1982-02-01
BG31074A3 (en) 1981-10-15
NO862107L (no) 1977-09-27
ES469287A1 (es) 1979-09-16
HK46882A (en) 1982-11-19
YU173783A (en) 1983-12-31
PT66346A (en) 1977-04-01
PT66346B (en) 1978-08-16

Similar Documents

Publication Publication Date Title
DK81277A (da) Fremgangsmade til fremstilling af bis-pyridinium-forbindelser
DK143706C (da) Fremgangsmaade til fremstilling af svovlholdige organosiliciumforbindelser
DK317180A (da) Fremgangsmaade til fremstilling af formddle
DK183277A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK152167C (da) Fremgangsmaade til fremstilling af drageer
DK323677A (da) Fremgangsmade til fremstilling af androstan-17-on-derivater
DK147777A (da) Fremgangsmade til fremstilling af acylchromaner
DK484576A (da) Fremgangsmade til fremstilling af 2-aroyl-3-phenyl-benzothiophenforbindelser
DK108680A (da) Fremgangsmaade til kontinuerlig fremstilling af mikrokapsler
DK142989C (da) Fremgangsmaade til fremstilling af furokumariner
DK57977A (da) Fremgangsmade til fremstilling af anilinforbindelser
DK144177A (da) Fremgangsmade til fremstilling af acylayanider
DK265978A (da) Fremgangsmaade til fremstilling af substituerede guanidiner
DK171678A (da) Fremgangsmaade til fremstilling af antibakterielt virksomme forbindelser
DK271780A (da) Fremgangsmaade til fremstilling af cephalosporinforbindelser
DK145877A (da) Fremgangsmade til immoblisering af glucoseisomerase
DK123277A (da) Fremgangsmade til fremstilling af 3-halogenmethyl-3-cephem-forbindelser
DK302777A (da) Fremgangsmade til fremstilling af karameller
DK151078A (da) Fremgangsmaade til fremstilling af cyclobutanoner
DK566977A (da) Fremgangsmaade til fremstilling af polyenforbindelser
DK20777A (da) Fremgangsmade til fremstilling af pyrrolidinforbindelser
DK52777A (da) Fremgangsmade til fremstilling af organiske forbindelser
DK247877A (da) Fremgangsmade til fremstilling af klavamforbindelser
DK65877A (da) Fremgangsmaade til fremstilling af mikrokapsler
DK31478A (da) Fremgangsmaade til fremstilling af aralkylaniliner

Legal Events

Date Code Title Description
PBP Patent lapsed